[Indications for determining serum levels of antiepileptic drugs (author's transl)]
- PMID: 579145
[Indications for determining serum levels of antiepileptic drugs (author's transl)]
Abstract
Measurement of the serum levels of antiepileptic drugs is an important progress in managing the patients with epilepsy. The determination of serum levels has become indispensable in special indications such as assessing the compliance in taking medication and identifying the responsible agent in intoxicated patients on multiple drug therapy. The long-term prognostic value of the routine determination of anticonvulsant drugs is related to the validity of the concept "therapeutic serum level".
Similar articles
-
[Determination of antiepileptic drug levels in the blood: day-to-day experience in an out-patient clinic for epilepic children (author's transl)].Wien Klin Wochenschr. 1979 Aug 10;91(15):517-20. Wien Klin Wochenschr. 1979. PMID: 382640 German.
-
[Pharmacokinetics of antiepileptic agents: their significance in the therapy of epilepsy].Schweiz Med Wochenschr. 1977 Oct 29;107(43):1513-24. Schweiz Med Wochenschr. 1977. PMID: 337467 Review. German.
-
Epilepsy in adults.Ann Neurol. 1981 Jan;9(1):3-16. doi: 10.1002/ana.410090103. Ann Neurol. 1981. PMID: 7011170 Review.
-
Clinical relevance of the determination of antiepileptic drugs in serum.Wien Klin Wochenschr Suppl. 1992;191:15-8. Wien Klin Wochenschr Suppl. 1992. PMID: 1509746 Review.
-
[Treatment of epileptics with the aid of antiepileptic drug blood level determinations (author's transl)].Nervenarzt. 1977 Apr;48(4):183-96. Nervenarzt. 1977. PMID: 323736 Review. German. No abstract available.
Cited by
-
Rational usage of therapeutic drug monitoring in antiepileptic treatment.Eur J Pediatr. 1980 May;133(3):193-9. doi: 10.1007/BF00496076. Eur J Pediatr. 1980. PMID: 6993208 Review. No abstract available.
-
A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy.J Neurol. 1981;224(3):193-201. doi: 10.1007/BF00313281. J Neurol. 1981. PMID: 6162015 Clinical Trial.